End-of-day quote
Korea S.E.
06:00:00 2024-05-26 pm EDT
|
5-day change
|
1st Jan Change
|
20,050
KRW
|
-0.99%
|
|
0.00%
|
-10.49%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
628,042
|
468,907
|
553,046
|
290,931
|
325,349
|
291,216
|
-
|
-
|
Enterprise Value (EV)
2 |
679.3
|
527.4
|
631.2
|
380.2
|
434.7
|
289.2
|
214.2
|
291.2
|
P/E ratio
|
28.3
x
|
41.8
x
|
19.3
x
|
-14.3
x
|
98.7
x
|
12.9
x
|
11.2
x
|
10.6
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
4.94
x
|
3.91
x
|
3.69
x
|
2.22
x
|
2.09
x
|
1.85
x
|
1.54
x
|
1.37
x
|
EV / Revenue
|
5.34
x
|
4.39
x
|
4.21
x
|
2.9
x
|
2.79
x
|
1.84
x
|
1.13
x
|
1.37
x
|
EV / EBITDA
|
15.6
x
|
13.3
x
|
13.7
x
|
43.4
x
|
13.1
x
|
7.05
x
|
4.23
x
|
4.85
x
|
EV / FCF
|
70.7
x
|
74.9
x
|
-48.9
x
|
-32.3
x
|
358
x
|
6.57
x
|
4.51
x
|
-
|
FCF Yield
|
1.42%
|
1.34%
|
-2.04%
|
-3.1%
|
0.28%
|
15.2%
|
22.2%
|
-
|
Price to Book
|
4.32
x
|
2.9
x
|
2.92
x
|
1.75
x
|
1.68
x
|
1.18
x
|
1.06
x
|
1.13
x
|
Nbr of stocks (in thousands)
|
14,953
|
14,815
|
14,807
|
14,768
|
14,524
|
14,524
|
-
|
-
|
Reference price
3 |
42,000
|
31,650
|
37,350
|
19,700
|
22,400
|
20,050
|
20,050
|
20,050
|
Announcement Date
|
2/18/20
|
1/27/21
|
2/28/22
|
2/22/23
|
1/19/24
|
-
|
-
|
-
|
1KRW in Million2KRW in Billions3KRW Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
127.2
|
120.1
|
150
|
131.3
|
155.8
|
157.1
|
188.8
|
212
|
EBITDA
1 |
43.61
|
39.55
|
46.22
|
8.764
|
33.21
|
41
|
50.67
|
60
|
EBIT
1 |
34.77
|
30.01
|
34.8
|
-4.405
|
20.9
|
29.55
|
39.93
|
46
|
Operating Margin
|
27.34%
|
24.99%
|
23.19%
|
-3.36%
|
13.41%
|
18.81%
|
21.15%
|
21.7%
|
Earnings before Tax (EBT)
1 |
35.4
|
16.48
|
33.81
|
-21.08
|
10.41
|
21.8
|
34.07
|
37
|
Net income
1 |
25.6
|
11.15
|
28.12
|
-20.46
|
2.923
|
19.8
|
26.63
|
30
|
Net margin
|
20.13%
|
9.29%
|
18.74%
|
-15.58%
|
1.88%
|
12.6%
|
14.11%
|
14.15%
|
EPS
2 |
1,483
|
758.0
|
1,932
|
-1,380
|
227.0
|
1,548
|
1,793
|
1,893
|
Free Cash Flow
3 |
9,615
|
7,043
|
-12,896
|
-11,774
|
1,215
|
44,000
|
47,500
|
-
|
FCF margin
|
7,561.12%
|
5,866.42%
|
-8,594.97%
|
-8,966.8%
|
779.98%
|
28,007.64%
|
25,158.9%
|
-
|
FCF Conversion (EBITDA)
|
22,049.14%
|
17,807.69%
|
-
|
-
|
3,660.09%
|
107,317.07%
|
93,749.99%
|
-
|
FCF Conversion (Net income)
|
37,556.59%
|
63,148.88%
|
-
|
-
|
41,579.02%
|
222,222.22%
|
178,347.96%
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/18/20
|
1/27/21
|
2/28/22
|
2/22/23
|
1/19/24
|
-
|
-
|
-
|
1KRW in Billions2KRW3KRW in Million Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
39.03
|
39.3
|
34.62
|
34.51
|
38.15
|
24.02
|
41.26
|
43.8
|
40.05
|
30.71
|
34.96
|
39.45
|
34.9
|
41.35
|
40.5
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
10.01
|
3.412
|
5.255
|
1.056
|
1.071
|
-11.79
|
10.13
|
10.23
|
6.512
|
-5.97
|
5.643
|
8.25
|
6.7
|
8.75
|
7.2
|
Operating Margin
|
25.64%
|
8.68%
|
15.18%
|
3.06%
|
2.81%
|
-49.07%
|
24.55%
|
23.35%
|
16.26%
|
-19.44%
|
16.14%
|
20.91%
|
19.2%
|
21.16%
|
17.78%
|
Earnings before Tax (EBT)
|
11.17
|
2.376
|
5.04
|
3.023
|
3.218
|
-32.36
|
14.67
|
5.093
|
6.01
|
-
|
-
|
6.4
|
3.7
|
5.5
|
6.1
|
Net income
1 |
8.882
|
1.997
|
2.343
|
1.899
|
1.544
|
-26.24
|
11.31
|
2.857
|
3.454
|
-14.31
|
4.206
|
6.55
|
5.6
|
6.45
|
4.8
|
Net margin
|
22.76%
|
5.08%
|
6.77%
|
5.5%
|
4.05%
|
-109.25%
|
27.42%
|
6.52%
|
8.63%
|
-46.61%
|
12.03%
|
16.6%
|
16.05%
|
15.6%
|
11.85%
|
EPS
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/2/21
|
2/28/22
|
5/13/22
|
8/16/22
|
11/14/22
|
2/22/23
|
5/15/23
|
7/20/23
|
11/14/23
|
1/19/24
|
5/16/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
51.3
|
58.5
|
78.2
|
89.3
|
109
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
2
|
77
|
-
|
Leverage (Debt/EBITDA)
|
1.176
x
|
1.479
x
|
1.692
x
|
10.19
x
|
3.295
x
|
-
|
-
|
-
|
Free Cash Flow
2 |
9,615
|
7,043
|
-12,896
|
-11,774
|
1,215
|
44,000
|
47,500
|
-
|
ROE (net income / shareholders' equity)
|
19.5%
|
7.46%
|
16.1%
|
-11.3%
|
1.61%
|
11.1%
|
11%
|
11.3%
|
ROA (Net income/ Total Assets)
|
10.3%
|
3.84%
|
8.44%
|
-6.03%
|
0.95%
|
5%
|
5.97%
|
5.6%
|
Assets
1 |
249.2
|
290.8
|
333.2
|
339.2
|
308
|
396
|
446.4
|
535.7
|
Book Value Per Share
3 |
9,717
|
10,913
|
12,783
|
11,237
|
13,356
|
17,049
|
18,889
|
17,698
|
Cash Flow per Share
3 |
657.0
|
1,299
|
427.0
|
-
|
374.0
|
3,360
|
3,775
|
-
|
Capex
1 |
16.3
|
11.4
|
17.4
|
10.7
|
4.22
|
13
|
12.5
|
19
|
Capex / Sales
|
12.82%
|
9.49%
|
11.62%
|
8.19%
|
2.71%
|
8.27%
|
6.62%
|
8.96%
|
Announcement Date
|
2/18/20
|
1/27/21
|
2/28/22
|
2/22/23
|
1/19/24
|
-
|
-
|
-
|
1KRW in Billions2KRW in Million3KRW Last Close Price
20,050
KRW Average target price
32,000
KRW Spread / Average Target +59.60% Consensus |
1st Jan change
|
Capi.
|
---|
| -10.49% | 215M | | +12.05% | 128B | | -9.24% | 10.88B | | -0.49% | 8.76B | | +36.99% | 5.48B | | +8.02% | 3.43B | | -10.32% | 2.76B | | -12.70% | 2.06B | | -13.26% | 1.92B | | -27.86% | 1.65B |
Medical Devices & Implants
|